Post Tagged with: "FDA"

NASDAQ: Big Victory For Marijuana And Its Researchers Looming Ahead

NASDAQ: Big Victory For Marijuana And Its Researchers Looming Ahead

But 16 years later things have changed, and the process required to begin research using marijuana or any cannabinoid-based compound is too long, arduous, and costly — and the Department of Health and Human Services realizes this. In consultation with the Food and Drug Administration, National Institutes of Health, and the Office of the Assistant Secretary for Health, the HHS […]

July 6, 2015 · 0 comments · Feature Article
GrowBLOX Announces Deployment of Commercial Units

GrowBLOX Announces Deployment of Commercial Units

Growblox Sciences, Inc. (GBLX), a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, announced today the receipt of production-model GrowBLOX(TM) units for both GB Sciences Nevada (GBSN) and GB Sciences Puerto Rico (GBS PR). “This is a major milestone for our company as it signals the transition from development to commercialization of […]

May 26, 2015 · 0 comments · Feature Article
FDA’s Decision To Legalize Marijuana

FDA’s Decision To Legalize Marijuana

Iowa House Majority Leader Linda Upmeyer, who has years of professional experience as a cardiology nurse practitioner, said Thursday any decision on legalizing medical marijuana should be determined by the federal Food and Drug Administration, not state lawmakers. The Food and Drug Administration (FDA) has not approved marijuana as a safe and effective drug, although many states permit medical use […]

April 10, 2015 · 0 comments · Feature Article
Penny Stocks Movers For Advanced Medical Isotope & Other Dispensaries

Penny Stocks Movers For Advanced Medical Isotope & Other Dispensaries

By the end of last trading, the Advanced Medical Isotope (OTCMKTS:ADMD) shares declined 17.91% (or US$0.00048) to US$0.00220 with about 103.33 million shares changing hands for the session, compared to its average volume of 43.54 million shares. The ticker first popped up on the investor’s radars in December when a couple of press releases dragged it out of triple-zero land. […]

March 30, 2015 · 0 comments · Feature Article
Penny Stocks Movers For Medican Enterprises, Advanced Medical Isotope & More

Penny Stocks Movers For Medican Enterprises, Advanced Medical Isotope & More

The ticker first popped up on the investor’s radars in December when a couple of press releases dragged it out of triple-zero land. Then, in January, it hesitated a bit, but at the end of last month, it embarked on another run. Over the last three and a half weeks, it has gained an impressive 237%. The company is a […]

March 25, 2015 · 0 comments · Feature Article
American Academy of Pediatrics Wants Cannabis Rescheduled

American Academy of Pediatrics Wants Cannabis Rescheduled

By definition, schedule I controlled substances are defined as possessing no “accepted medical use.” Clinical protocols involving cannabis are strictly controlled and require authorization from various federal agencies, including DEA, FDA, and the National Institute on Drug Abuse (NIDA) – the latter of which is designated under federal law as the sole provider of cannabis and/or organic cannabinoids for research […]

January 28, 2015 · 0 comments · Feature Article
Make Sure These Cannabis Stocks Are In Your Winning Portfolio

Make Sure These Cannabis Stocks Are In Your Winning Portfolio

In the small cap space, Oxis International through its subsidiary, Oxis Biotech, has been captivating penny stock traders over the last few weeks. Material announcements include the addition of two key members to the company’s scientific advisory board. These include the likes of the foremost authority on CBD research, Dr. Sean Xie as well as Dr. James Mule who also […]

January 25, 2015 · 0 comments · Feature Article
What You Need To Know Regarding Medical Pot This Year

What You Need To Know Regarding Medical Pot This Year

It’s also been studying CBD for use in epilepsy. In 2015, GW Pharma is going to roll out more data that investors will be able to dissect and digest, to see whether or not they want to be long the stock heading into the 2016 election year cycle. Personally, I’m not a huge fan of GW Pharma for 2015 because […]

January 25, 2015 · 0 comments · Feature Article
What The Public Should Know About Marijuana Stocks For 2015

What The Public Should Know About Marijuana Stocks For 2015

But when you look at their price to sales, for example, for the trailing 12 months, it’s 33 according to Yahoo! Finance. That is a pretty substantial … that’s priced to perfection, and I think that there are a couple of concerns there. For me, one of the big ones is there’s an election that says, “We’re legalizing marijuana in […]

January 21, 2015 · 0 comments · Feature Article
Strategic Collaboration Entered By Therapix Biosciences

Strategic Collaboration Entered By Therapix Biosciences

Pursuant to the memorandum of understanding, OrImmune and Nanjing BioSciKin are working toward an agreement that would provide Nanjing BioSciKin with an exclusive license to use OrImmune’s patents and related intellectual property for the purpose of research, development, manufacture, commercialization and sublicensing in the territory, in consideration for a cash payment of US $300,000. Additionally, Nanjing BioSciKin will be expected […]

December 24, 2014 · 0 comments · Feature Article